Statins may potentiate bisphosphonates anticancer properties: a new pharmacological approach?

This publication has 25 references indexed in Scilit:

• Stimulation of γδ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma
  Blood, 2000
• Bisphosphonates and the prevention of metastasis
  Cancer, 2000
• Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines
  Leukemia, 2000
• Bisphosphonates induce apoptosis in human breast cancer cell lines
  British Journal of Cancer, 2000
• Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro
  Proceedings of the National Academy of Sciences, 1999
• The Effect of Alendronate on Cytokine Production, Adhesion Molecule Expression, and Transendothelial Migration of Human Peripheral Blood Mononuclear Cells
  Calcified Tissue International, 1998
• Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including Ras
  Journal of Bone and Mineral Research, 1998
• Protein-tyrosine phosphatase activity regulates osteoclast formation and function: inhibition by alendronate.
  Proceedings of the National Academy of Sciences, 1996
• Interleukin-6 and tumor necrosis factor α levels after bisphosphonates treatment in vitro and in patients with malignancy
  Bone, 1996
• Pamidronate
  Drugs, 1991